Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20609970 | 0.89 | TSHR (0.46) | TSHRTDP1 | |
| SCHEMBL21874951 | 0.81 | TSHR (0.36) | TSHRTDP1 | |
| SCHEMBL18799382 | 0.80 | TSHR (0.41) | TSHRTDP1 | |
| SCHEMBL28268972 | 0.78 | TSHR (0.39) | TSHRTDP1 | |
| SCHEMBL21925391 | 0.76 | TSHR (0.35) | TSHRTDP1 | |
| SCHEMBL17607595 | 0.76 | TSHR (0.35) | TSHRTDP1 | |
| SCHEMBL598853 | 0.76 | TSHR (0.46) | TSHRTDP1 | |
| SCHEMBL4406661 | 0.74 | — | — | |
| SCHEMBL56625 | 0.74 | — | — | |
| SCHEMBL27160388 | 0.74 | TDP1 (0.40) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040586-A1 | 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | GILEAD SCIENCES, INC. | 2023-02-09 | — | — | US | disclosed |
| US-20200171214-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | DREI LILIEN PVG GMBH & CO. KG (DE) | 2020-06-04 | — | — | US | disclosed |
| EP-3648806-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | Drei Lilien PVG GmbH & Co. KG (DE) | 2020-05-13 | — | — | EP | disclosed |
| WO-2019008192-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | DREI LILIEN PVG GMBH & CO. KG (DE) | 2019-01-10 | — | — | WO | disclosed |
| WO-2001056965-A2 | MANUFACTURING PROCESS FOR THE PREPARATION OF α,α,α\",α\"-BRANCHED DICARBOXYLIC ACIDS | RESOLUTION RESEARCH NEDERLAND B.V. (NL) | 2001-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230040586-A1 | 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | TYMP, PNP, DUT | TSHR 4786/4885TDP1 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.